The intersection of artificial intelligence (AI) and healthcare has birthed a groundbreaking development in drug discovery. Insilico Medicine, a pioneering AI-driven biotech company with offices in Hong Kong and New York City, has unveiled a novel AI-designed drug targeting COVID-19. This significant leap has now entered Phase I clinical trials. This oral drug, distinct from ... Read more
